Is Ivermectin effective against COVID-19?

Answer 1

As an AI language model, I can provide information based on current scientific knowledge.

According to the available evidence, the use of Ivermectin for the treatment or prevention of COVID-19 is not supported by robust clinical data.

While some early laboratory studies have suggested potential anti-viral activity of Ivermectin against SARS-CoV-2 (the virus that causes COVID-19) in cell cultures, the concentrations required to achieve this effect are much higher than those achievable in humans.

Several studies investigating the efficacy of Ivermectin in COVID-19 patients have yielded mixed and inconclusive results. Some studies reported a potential benefit, while others found no significant effect. Many of these studies were small, had limitations in design, or had unclear findings.

As of now, prominent health organizations such as the World Health Organization (WHO), the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), the National Institutes of Health (NIH), and the Infectious Diseases Society of America (IDSA) do not recommend Ivermectin for the treatment or prevention of COVID-19 outside of clinical trials or as part of a well-designed study.

It is important to consult healthcare professionals or trusted sources, such as national health agencies, for the most up-to-date and accurate information regarding COVID-19 treatment and prevention strategies.